MilliporeSigma
  • Home
  • Search Results
  • microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.

microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.

Oncotarget (2014-10-31)
Jia Wang, Eagle S H Chu, Hai-Yong Chen, Kwan Man, Minnie Y Y Go, Xiao Ru Huang, Hui Yao Lan, Joseph J Y Sung, Jun Yu
ABSTRACT

microRNA-29b (miR-29b) is known to be associated with TGF-β-mediated fibrosis, but the mechanistic action of miR-29b in liver fibrosis remains unclear and is warranted for investigation. We found that miR-29b was significantly downregulated in human and mice fibrotic liver tissues and in primary activated HSCs. miR-29b downregulation was directly mediated by Smad3 through binding to the promoter of miR-29b in hepatic stellate cell (HSC) line LX1, whilst miR-29b could in turn suppress Smad3 expression. miR-29b transduction in the liver of mice prevented CCl4 induced-fibrogenesis, concomitant with decreased expression of α-SMA, collagen I and TIMP-1. Ectopic expression of miR-29b in activated HSCs (LX-1, HSC-T6) inhibited cell viability and colony formation, and caused cell cycle arrest in G1 phase by downregulating cyclin D1 and p21cip1. Further, miR-29b induced apoptosis in HSCs mediated by caspase-9 and PARP. miR-29b inhibited its downstream effectors of PIK3R1 and AKT3 through direct targeting their 3'UTR regions. Moreover, knockdown of PIK3R1 or AKT3 suppressed α-SMA and collagen I and induced apoptosis in both HSCs and in mice. In conclusion, miR-29b prevents liver fibrogenesis by inhibiting HSC activation and inducing HSC apoptosis through inhibiting PI3K/AKT pathway. These results provide novel mechanistic insights for the anti-fibrotic effect of miR-29b.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Adenosine 5′-diphosphoribose sodium salt, ≥93%
Sigma-Aldrich
Propidium iodide solution, solution (1.0 mg/ml in water)
Supelco
Doxycycline hyclate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Carbon tetrachloride, anhydrous, ≥99.5%
Sigma-Aldrich
Propidium iodide, ≥94% (HPLC)
Supelco
Doxycycline hyclate, VETRANAL®, analytical standard
Supelco
Carbon tetrachloride, analytical standard
Sigma-Aldrich
Propidium iodide, ≥94.0% (HPLC)
Sigma-Aldrich
Doxycycline hyclate
Sigma-Aldrich
Carbon tetrachloride, reagent grade, 99.9%
Doxycycline hyclate, European Pharmacopoeia (EP) Reference Standard
Supelco
Carbon tetrachloride, suitable for HPLC, ≥99.9%
USP
Doxycycline hyclate, United States Pharmacopeia (USP) Reference Standard